What is the CVSS score of CVE-2023-41149?

CVE-2023-41149 has a CVSS 3.1 base score of 9.8 (Critical). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 1.3%.

F Revocrm CVE-2023-41149

CRITICAL

OS Command Injection (CWE-78)

2023-09-06 vultures@jpcert.or.jp

Command Injection F Revocrm

9.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

9.8 CRITICAL

AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Sep 06, 2023 - 13:15 nvd

CRITICAL 9.8

DescriptionNVD

F-RevoCRM version7.3.7 and version7.3.8 contains an OS command injection vulnerability. If this vulnerability is exploited, an attacker who can access the product may execute an arbitrary OS command on the server where the product is running.

AnalysisAI

F-RevoCRM version7.3.7 and version7.3.8 contains an OS command injection vulnerability. Rated critical severity (CVSS 9.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified as OS Command Injection (CWE-78), which allows attackers to execute arbitrary operating system commands on the host. F-RevoCRM version7.3.7 and version7.3.8 contains an OS command injection vulnerability. If this vulnerability is exploited, an attacker who can access the product may execute an arbitrary OS command on the server where the product is running. Affected products include: F-Revocrm.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Avoid passing user input to shell commands. Use language-specific APIs instead of shell execution. Apply strict input validation with allowlists.